What Is The Current and Historic Market Size Analysis Of Hemodynamic Flow Alteration Devices Market?
The hemodynamic flow alteration devices market has seen considerable growth due to a variety of factors.
• The market size for hemodynamic flow alteration devices has seen considerable growth in the past few years. The forecasted growth is from $0.82 billion in 2024 to $0.89 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.2%.
This consistent growth seen during the historic period can be linked to factors such as the increasing age of the population, enhancements in healthcare spending, a surge in cardiovascular disease occurrence, a rise in risk contributors like obesity, diabetes, and hypertension, coupled with an upswing in research and development.
What Are The Predictions for The Hemodynamic Flow Alteration Devices Market Size In The Coming Years?
The hemodynamic flow alteration devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations are high for robust expansion in the hemodynamic flow alteration devices market in the forthcoming years, with predictions of reaching $1.21 billion by 2029, accompanying a compound annual growth rate (CAGR) of 7.9%.
The anticipated growth during this period can be linked to factors such as rocketing instances of neurovascular ailments, inclination towards minimally invasive neurosurgery, expanding elderly population, heightened thrombotic events risk, and elevating disposable income. In the forecast period, the market is set to be shaped by trending factors including minimally invasive techniques, progress in biocompatible substances, wearable surveillance systems, the inception of artificial intelligence and machine learning, and amalgamation with cardiac monitoring systems.
Which Factors Are Boosting Growth In The Hemodynamic Flow Alteration Devices Market?
The rise in instances of cardiovascular ailments is predicted to stimulate growth in the hemodynamic flow alteration devices market. Cardiovascular disease (CVD), a term for various conditions impacting the heart and blood vessels, is becoming more prevalent due to factors such as aging population, unhealthy diets, lack of physical activity, and increasing instances of health conditions like hypertension and diabetes. Since these devices aid in improving and managing blood circulation in patients suffering from conditions like heart failure, hypertension, and blocked arteries, they see increased demand due to cardiovascular diseases. For example, the British Heart Foundation estimated in September 2024 that about 7.6 million people in the UK, comprising 4 million men and 3.6 million women, are currently living with heart and circulatory diseases. By 2030, this figure is expected to rise by 1 million, and could further increase by 2 million by 2040, compared to current figures. As such, the escalating prevalence of cardiovascular disease is projected to stimulate the hemodynamic flow alteration devices market.
What Are The Core Segments Of The Globa Hemodynamic Flow Alteration Devices Market?
The hemodynamic flow alteration devices market covered in this report is segmented –
1) By Type: Embolic Protection Device, Chronic Total Occlusion Device
2) By Application: Cardiovascular Diseases, Neurological Disorders, Renal Disorders, Respiratory Disorders
3) By End User: Hospitals, Clinics, Ambulatory Care Centre, Home Care Setting, Other End Users
Subsegments:
1) By Embolic Protection Device: Distal Embolic Protection Devices, Proximal Embolic Protection Devices, Filter-Based Embolic Protection Devices, Balloon-Based Embolic Protection Devices, Mesh Or Cage-Based Embolic Protection Devices
2) By Chronic Total Occlusion Device: Crossing Guidewires For CTO, CTO Balloon Catheters, CTO Microcatheters, Re-Entry Devices For CTO, CTO Support Catheters
Pre-Book The Hemodynamic Flow Alteration Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Hemodynamic Flow Alteration Devices Market Size?
Key businesses in the hemodynamic flow alteration devices industry are working on cutting-edge solutions including left ventricular assist devices, with the goal to strengthen heart support, elevate patient outcomes, and meet the global increase in heart failure cases. A left ventricular assist device (LVAD) comprises a mechanically operated pump that is medically placed in patients grappling with intense heart failure. As an example, in January 2022, a notable project was initiated by the Indian Institute of Technology-Kanpur, a government-based research institution in India. The project titled Hridyantra seeks to develop a highly advanced artificial heart, specifically a Left Ventricular Assist Device (LVAD). The endeavor is aimed at catering to the requirements of patients dealing with terminal heart failure through the creation of a sophisticated cardiac assistance device that is intended to act as a holding measure before a heart transplant or a perpetual solution for patients who are not suitable for transplant surgery.
Who Are the Key Players in the Hemodynamic Flow Alteration Devices Market?
Major companies operating in the hemodynamic flow alteration devices market are include:
• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic plc
• Siemens Healthcare GmbH
• Becton Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• W. L. Gore & Associates Inc.
• ZOLL Medical Corporation
• Getinge AB
• Lepu Medical Technology (Beijing) Co. Ltd.
• Abiomed Inc.
• LivaNova PLC
• Cordis US Corp.
• Silk Road Medical Inc.
• Berlin Heart GmbH
• CorWave SA
• Jarvik Heart Inc.
• CARMAT SA
What are the Regional Insights into the Hemodynamic Flow Alteration Devices Market?
North America was the largest region in the hemodynamic flow alteration devices market in 2024. The regions covered in the hemodynamic flow alteration devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
